A Novel Human Interleukin-23A Overexpressing Mouse Model of Systemic Lupus Erythematosus.

Autor: Christodoulou-Vafeiadou E; Biomedcode Hellas SA, Athens, Greece., Geka C; Biomedcode Hellas SA, Athens, Greece., Iliopoulou L; Biomedical Sciences Research Center (BSRC) Alexander Fleming, Athens, Greece., Ntari L; Biomedcode Hellas SA, Athens, Greece., Denis MC; Biomedcode Hellas SA, Athens, Greece., Karagianni N; Biomedcode Hellas SA, Athens, Greece., Kollias G; BSRC Alexander Fleming, Athens, Greece, and School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Publikováno v: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2024 Jul; Vol. 76 (7), pp. 1085-1095. Date of Electronic Publication: 2024 Apr 02.

Ectopic bone formation and systemic bone loss in a transmembrane TNF-driven model of human spondyloarthritis

Autor: Christodoulou-Vafeiadou, E. Geka, C. Ntari, L. Kranidioti, K. Argyropoulou, E. Meier, F. Armaka, M. Mourouzis, I. Pantos, C. Rouchota, M. Loudos, G. Denis, M.C. Karagianni, N. Kollias, G.

Background: The transmembrane-TNF transgenic mouse, TgA86, has been shown to develop spontaneously peripheral arthritis with signs of axial involvement. To assess similarity to human spondyloarthritis, we performed detailed characterization of the ax

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::e87e55ba7ca2fdacae17c1ffd0e7b132
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3000121

'SMASH' recommendations for standardised microscopic arthritis scoring of histological sections from inflammatory arthritis animal models.

Autor: Hayer S; Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Wien, Austria silvia.hayer@meduniwien.ac.at., Vervoordeldonk MJ; Arthrogen BV, Amsterdam, The Netherlands.; Present address: GlaxoSmithKline, Stevenage, UK., Denis MC; Biomedcode Hellas SA, Vari, Greece., Armaka M; Department of Immunology, Biomedical Sciences Research Centre 'Alexander Fleming', Vari, Greece., Hoffmann M; Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, Erlangen, Germany., Bäcklund J; Department of Medical Biochemistry and Biophysics, Division of Medical Inflammation Research, Karolinska Institute, Stockholm, Sweden., Nandakumar KS; Department of Medical Biochemistry and Biophysics, Division of Medical Inflammation Research, Karolinska Institute, Stockholm, Sweden.; School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China., Niederreiter B; Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Wien, Austria., Geka C; Biomedcode Hellas SA, Vari, Greece., Fischer A; Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Wien, Austria.; Ludwig Boltzmann Institute for Arthritis and Rehabilitation, Vienna, Austria., Woodworth N; Redoxis AB/ProNoxis AB, Lund, Sweden., Blüml S; Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Wien, Austria., Kollias G; Department of Immunology, Biomedical Sciences Research Centre 'Alexander Fleming', Vari, Greece.; Department of Physiology, Medical School, University of Athens, Athens, Greece., Holmdahl R; Department of Medical Biochemistry and Biophysics, Division of Medical Inflammation Research, Karolinska Institute, Stockholm, Sweden., Apparailly F; IRMB, INSERM, University of Montpellier, Montpellier, France., Koenders MI; Department of Rheumatology, Radboud University Medical Center, Nijmegen, The Netherlands.

Publikováno v: Annals of the rheumatic diseases [Ann Rheum Dis] 2021 Jun; Vol. 80 (6), pp. 714-726. Date of Electronic Publication: 2021 Feb 18.

Combination of subtherapeutic anti-TNF dose with dasatinib restores clinical and molecular arthritogenic profiles better than standard anti-TNF treatment.

Autor: Ntari L; Biomedcode Hellas SA, Vari, Greece., Nikolaou C; Institute for Bioinnovation, Biomedical Sciences Research Center (BSRC), Alexander Fleming, 34 Alexander Fleming Street, 16672, Vari, Greece., Kranidioti K; Biomedcode Hellas SA, Vari, Greece., Papadopoulou D; Institute for Bioinnovation, Biomedical Sciences Research Center (BSRC), Alexander Fleming, 34 Alexander Fleming Street, 16672, Vari, Greece., Christodoulou-Vafeiadou E; Biomedcode Hellas SA, Vari, Greece., Chouvardas P; Department of Medical Oncology, Inselspital, University Hospital and University of Bern, Bern, Switzerland.; Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland., Meier F; Division of Rheumatology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.; Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP, Frankfurt am Main, Germany., Geka C; Biomedcode Hellas SA, Vari, Greece., Denis MC; Biomedcode Hellas SA, Vari, Greece., Karagianni N; Biomedcode Hellas SA, Vari, Greece., Kollias G; Institute for Bioinnovation, Biomedical Sciences Research Center (BSRC), Alexander Fleming, 34 Alexander Fleming Street, 16672, Vari, Greece. kollias@fleming.gr.; Department of Physiology and Joint Rheumatology Program, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. kollias@fleming.gr.

Publikováno v: Journal of translational medicine [J Transl Med] 2021 Apr 23; Vol. 19 (1), pp. 165. Date of Electronic Publication: 2021 Apr 23.

Free Fatty Acid 4 Receptor Activation Attenuates Collagen-Induced Arthritis by Rebalancing Th1/Th17 and Treg Cells.

Autor: Lee, Jung-Eun¹ (AUTHOR) xkdnj1005@khu.ac.kr, Lee, Ju-Hyun¹ (AUTHOR) ljh0620@khu.ac.kr, Koh, Jung-Min² (AUTHOR) jmkoh@amc.seoul.kr, Im, Dong-Soon^1,2 (AUTHOR) imds@khu.ac.kr

Publikováno v: International Journal of Molecular Sciences. Jun2024, Vol. 25 Issue 11, p5866. 16p.